Compare ATEC & BSTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ATEC | BSTZ |
|---|---|---|
| Founded | 1990 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.5B |
| IPO Year | 2006 | N/A |
| Metric | ATEC | BSTZ |
|---|---|---|
| Price | $11.52 | $24.22 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $22.00 | N/A |
| AVG Volume (30 Days) | ★ 2.0M | 161.4K |
| Earning Date | 04-30-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.31% |
| EPS Growth | ★ 15.04 | N/A |
| EPS | N/A | ★ 0.71 |
| Revenue | ★ $101,739,000.00 | N/A |
| Revenue This Year | $18.97 | N/A |
| Revenue Next Year | $16.70 | N/A |
| P/E Ratio | ★ N/A | $33.73 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $9.89 | $16.12 |
| 52 Week High | $23.29 | $23.98 |
| Indicator | ATEC | BSTZ |
|---|---|---|
| Relative Strength Index (RSI) | 44.90 | 68.45 |
| Support Level | $10.31 | $22.07 |
| Resistance Level | $13.08 | N/A |
| Average True Range (ATR) | 0.54 | 0.55 |
| MACD | 0.11 | 0.25 |
| Stochastic Oscillator | 60.43 | 99.53 |
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. Its procedural offerings are designed to address the underlying causes of spinal pathology by advancing the three fundamental objectives of spine surgery: (1) decompression of neural elements, (2) stabilization of spinal segments, and (3) restoration and maintenance of proper spinal alignment.
BlackRock Science and Technology Trust II is a non-diversified, closed-end management investment company. The trust's investment objectives are to provide total return and income through a combination of current income, current gains, and long-term capital appreciation. Its portfolio consists of Equity Securities, Options, Preferred Securities, Convertible Securities, Depositary Receipts, Non-U.S. Securities, Emerging Markets Investments, Restricted and Illiquid Investments, Private Company Investments, Corporate Bonds, and other investments. The trust seeks to Invest at least 80% of its total assets in equity securities issued by U.S. and non-U.S. science and technology companies in any market capitalization range from the development, advancement, and use of science and/or technology.